Funga-Stop Formula
In vendita sul mercato statunitense (secondo il DSLD)
Woodstock Herbal Products, integratore alimentare del mercato statunitense
Funga-Stop Formula (Woodstock Herbal Products), integratore alimentare au code-barres 854245005203, è descritto dalla sua etichetta per il mercato statunitense. Se venduto in Francia, sarebbe interessato da 2 punti della normativa francese o europea, illustrati di seguito. La formula venduta in Europa con lo stesso nome può essere diversa.
Etichetta ufficiale. Dietary Supplement Label Database (DSLD), National Institutes of Health statunitensi (NIH): etichette in vendita o ritirate dal mercato, consultato il 27 ottobre 2026.
Fonte: NIH, Office of Dietary Supplements, Dietary Supplement Label Database (CC0); etichette del mercato statunitense.
Se questo prodotto fosse venduto in Francia
- Condizioni legali
Trifolium pratense L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
Fonte: Decreti francesi del 9 maggio 2006 (nutrienti), del 24 giugno 2014 (piante) e del 26 settembre 2016 (altre sostanze), raccolta LEGI consolidata, arrêté du 24 juin 2014, annexe I.
- Condizioni legali
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
Fonte: Decreti francesi del 9 maggio 2006 (nutrienti), del 24 giugno 2014 (piante) e del 26 settembre 2016 (altre sostanze), raccolta LEGI consolidata, arrêté du 24 juin 2014, annexe I.
Una dose giornaliera si calcola solo se l’etichetta indica il numero massimo di assunzioni e un’unità di massa (o unità internazionali per la vitamina D). Le quantità provengono dall’etichetta, non da un’analisi. Negli Stati Uniti, l’etichetta presenta il prodotto come «dietary supplement»; in Francia, un prodotto di questo tipo può rientrare in un’altra categoria (per esempio una polvere per sportivi) e le dosi massime degli integratori alimentari non si applicano.
Composizione dell’etichetta
- Marca
- Woodstock Herbal Products
- Codice a barre
- 854245005203
- Forma
- Liquido
- Un’assunzione
- 0,5 ml
- Assunzioni
- al massimo 5 assunzioni al giorno
- Altri ingredienti (in inglese, come scritti)
Testo originale in inglese.
Alcohol
| Ingrediente (come scritto, in inglese) | Categoria | Per assunzione |
|---|---|---|
| Proprietary Extract Blend | Miscela | 450 mg |
| Black Walnut Husk Extract (Juglans nigra) | Pianta | non indicata |
| Barberry root bark extract | Pianta | non indicata |
| Chaparral Aerial Parts Extract (Larrea tridentata) | Pianta | non indicata |
| Condurango bark extract (Marsdenia cundurango) | Pianta | non indicata |
| Dandelion root extract | Pianta | non indicata |
| Goldenseal root extract (Hydrastis canadensis) | Pianta | non indicata |
| Neem leaf extract (Azadirachta indica) | Pianta | non indicata |
| Olive leaf extract | Pianta | non indicata |
| Oregano Leaf Extract | Pianta | non indicata |
| Pau d'Arco bark extract (Handroanthus impetiginosus) | Pianta | non indicata |
| Red Clover flowering tops extract (Trifolium pratense) | Pianta | non indicata |
| White WIllow bark extract (Salix alba) | Pianta | non indicata |
Etichetta presentata: Etichetta ufficiale. Si privilegiano le etichette in vendita, poi la più recente per lo stesso stato.
Queste informazioni riprendono l’etichetta statunitense registrata dagli Istituti nazionali di sanità degli Stati Uniti (NIH). Non dicono se il prodotto sia efficace e non sostituiscono il parere di un medico o farmacista, in particolare in gravidanza o durante un trattamento.
Avvertenze ufficiali (Health Canada)
Health Canada pubblica avvertenze su questi ingredienti:
- Goldenseal root extract
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
GOLDENSEAL - HYDRASTIS CANADENSIS - Buccal
Precauzioni e avvertenze
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Ask a health care practitioner/health care provider/health care professional/ doctor/physician before use if you have a kidney or blood pressure disorder (Brinker 2010; Hoffmann 2003).
Fonti citate da Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
Controindicazioni
Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes and al. 2007; Mills and Bone 2005; Boon and Smith 2004; Hoffmann 2003; Bradley 1992).
Fonti citate da Health Canada (7)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (GB): The Pharmaceutical Press; 2007.
- Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
- Bradley PR, editor. British Herbal Compendium, Volume 1. Bournemouth (GB): British Herbal Medicine Association; 1992.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Raton (FL): Taylor and Francis Group; 2013.
- Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Monografia di Health Canada del 28 marzo 2025
GOLDENSEAL - HYDRASTIS CANADENSIS - Oral
Precauzioni e avvertenze
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional before use if you have a kidney or blood pressure disorder (Brinker 2010; Hoffmann 2003).
Fonti citate da Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Hoffmann D. 2003. Medical Herbalism. Rochester (VT): Healing Arts Press.
Controindicazioni
Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes and al. 2007; Mills and Bone 2005; Boon and Smith 2004; Hoffmann 2003; Bradley 1992).
Fonti citate da Health Canada (7)
- Barnes J, Anderson LA, Philipson JD. 2007. Herbal Medicines, 3rd edition. London (GB): The Pharmaceutical Press.
- Boon H, Smith MJ. 2004. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc.
- Bradley PR, editor. 1992. British Herbal Compendium, Volume 1. Bournemouth (GB): British Herbal Medicine Association.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.
- Hoffmann D. 2003. Medical Herbalism. Rochester (VT): Healing Arts Press.
- Mills S, Bone K. 2005. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone.
- White WIllow bark extract
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
WILLOW BARK
Via di somministrazione: Oral
Precauzioni e avvertenze
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have asthma or peptic ulcer disease (EMA 2017).
Fonti citate da Health Canada (1)
- EMA 2017 European Medicines Agency. European Union herbal monograph on Salix [various species including S. purpurea L., S. daphnoides Vill., S. fragilis L.], cortex. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 31 January 2017. [Accessed 2023 October 14].Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-salix-various-species-including-s-purpurea-l-s-daphnoides-vill_en.pdf
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or products containing salicylates (e.g., acetylsalicylic acid or non-steroidal anti-inflammatory drugs) (EMA 2017).
Fonti citate da Health Canada (1)
- EMA 2017 European Medicines Agency. European Union herbal monograph on Salix [various species including S. purpurea L., S. daphnoides Vill., S. fragilis L.], cortex. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 31 January 2017. [Accessed 2023 October 14].Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-salix-various-species-including-s-purpurea-l-s-daphnoides-vill_en.pdf
Controindicazioni
Do not use if you are pregnant or breastfeeding (EMA 2017; Brinker 2010; Wichtl 2004; ESCOP 2003; Barnes et al. 2002; Blumenthal et al. 2000).
Fonti citate da Health Canada (6)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines: A Guide for Healthcare Professionals. 2nd edition. London (GB): The Pharmaceutical Press; 2002.
- Blumenthal M, Goldberg A, Brinckmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 3rd edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2017 European Medicines Agency. European Union herbal monograph on Salix [various species including S. purpurea L., S. daphnoides Vill., S. fragilis L.], cortex. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 31 January 2017. [Accessed 2023 October 14].Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-salix-various-species-including-s-purpurea-l-s-daphnoides-vill_en.pdf
- ESCOP 2003: E/S/C/O/P Monographs: The Scientific Foundation for Herbal Medicinal Products. 2nd edition. Exeter (GB): ESCOP, the European Scientific Cooperative on Phytotherapy in collaboration with Georg Thieme Verlag and Thieme; 2003.
- Wichtl M, editor. Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis. 3rd edition. Stuttgart (DE): Medpharm Scientific Publishers; 2004.
Do not use if you are allergic to salicylates (EMA 2017; Brinker 2010; Wichtl 2004, ESCOP 2003; Barnes et al. 2002; Blumenthal et al. 2000).
Fonti citate da Health Canada (6)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines: A Guide for Healthcare Professionals. 2nd edition. London (GB): The Pharmaceutical Press; 2002.
- Blumenthal M, Goldberg A, Brinckmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 3rd edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2017 European Medicines Agency. European Union herbal monograph on Salix [various species including S. purpurea L., S. daphnoides Vill., S. fragilis L.], cortex. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 31 January 2017. [Accessed 2023 October 14].Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-salix-various-species-including-s-purpurea-l-s-daphnoides-vill_en.pdf
- ESCOP 2003: E/S/C/O/P Monographs: The Scientific Foundation for Herbal Medicinal Products. 2nd edition. Exeter (GB): ESCOP, the European Scientific Cooperative on Phytotherapy in collaboration with Georg Thieme Verlag and Thieme; 2003.
- Wichtl M, editor. Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis. 3rd edition. Stuttgart (DE): Medpharm Scientific Publishers; 2004.
Reazioni avverse note
When using this product you may experience gastrointestinal discomfort/disturbances (EMA 2017; Brinker 2010; Wichtl 2004; ESCOP 2003; Barnes et al. 2002; Blumenthal et al. 2000)
Fonti citate da Health Canada (6)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines: A Guide for Healthcare Professionals. 2nd edition. London (GB): The Pharmaceutical Press; 2002.
- Blumenthal M, Goldberg A, Brinckmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 3rd edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2017 European Medicines Agency. European Union herbal monograph on Salix [various species including S. purpurea L., S. daphnoides Vill., S. fragilis L.], cortex. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 31 January 2017. [Accessed 2023 October 14].Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-salix-various-species-including-s-purpurea-l-s-daphnoides-vill_en.pdf
- ESCOP 2003: E/S/C/O/P Monographs: The Scientific Foundation for Herbal Medicinal Products. 2nd edition. Exeter (GB): ESCOP, the European Scientific Cooperative on Phytotherapy in collaboration with Georg Thieme Verlag and Thieme; 2003.
- Wichtl M, editor. Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis. 3rd edition. Stuttgart (DE): Medpharm Scientific Publishers; 2004.
Riguardano l'ingrediente, non questo prodotto né la sua dose. Non sostituiscono il parere medico.
Elenco dichiarato il (registro: Dietary Supplement Label Database (DSLD), National Institutes of Health statunitensi (NIH): etichette in vendita o ritirate dal mercato).
Il prodotto è cambiato? Fotografi la confezione.
Marca : Woodstock Herbal Products
Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.